Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...

Zoryve is under clinical development by Arcutis Biotherapeutics and currently in Pre-Registration for Psoriasis.

Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...

The rally in ARQT's stock could be attributed to the encouraging regulatory updates seeking label expansion for its sole marketed drug.

Has your skin ever felt a little more irritable than usual? If you ever had itchy, red or flaky patches that look ...

H.C. Wainwright analyst Douglas Tsao initiated coverage of Arcutis Biotherapeutics (ARQT) with a Buy rating and $19 price target The firm ...

RML Hospital's clinical study reports that Tofacitinib shows a remarkable 90% improvement in chronic hand eczema symptoms for 12 of 15 patients within four weeks. The condition primarily affects ...

HealthDay News — The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older. The approval ...

One of these is seborrheic eczema, also called seborrheic dermatitis ... For example, you might be able to stop using steroid creams. However, if needed, you can usually combine biologics with topical ...

A woman left in agony when she had a reaction to a steroid cream said the pain was worse ... from the use to treat a skin problem, such as eczema. At its worst she is unable to able to sleep ...

breakthrough in treating psoriasis and eczema. The cream, called Zambesia Botanica, containing extracts of the fruit of an African tree, has been found to relieve itchiness and ease other symptoms ...